CCL2 and cancer: Specifically, cancer and microenvironmental cell-secreted IDO1, IL-10, C-C motif chemokine ligand 2 (CCL2) and transforming growth factor beta (TGF-β) promote the expansion of immunosuppressive Tregs within the GBM TME [186].